BRIAN CLAY: Open Payments
NPI 1295463784 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 31 payments from 13 companies in 2025. Trend: 2023 $191 · 2024 $154 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $197 |
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Amgen Inc. | 4 | $59 |
| PFIZER INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $39 |
| Dexcom, Inc. | 2 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
Products named: Wegovy, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, BREZTRI, JARDIANCE, ELIQUIS, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
